###begin article-title 0
###xml 41 44 <span type="species:ncbi:10116">rat</span>
 Creatine synthesis and transport during rat embryogenesis: Spatiotemporal expression of AGAT, GAMT and CT1
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 559 562 <span type="species:ncbi:10116">rat</span>
Creatine (Cr) is synthesized by a two-step mechanism involving arginine:glycine amidinotransferase (AGAT) and guanidinoacetate methyltransferase (GAMT), and is taken up by cells through a specific Cr transporter, CT1. Recently, genetic defects of this pathway have been described, that lead to Cr deficiency, neurological symptoms in early infancy and severe neurodevelopmental delay. To investigate the involvement of Cr synthesis and uptake pathways during embryonic development, we determined the spatiotemporal expression of AGAT, GAMT and CT1 during the rat embryogenesis, at the mRNA and protein level.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
We show that AGAT and GAMT are expressed in hepatic primordium as soon as 12.5 days, then progressively acquire their adult pattern of expression, with high levels of AGAT in kidney and pancreas, and high levels of GAMT in liver and pancreas. AGAT and CT1 are prominent in CNS, skeletal muscles and intestine, where they appear earlier than GAMT. High levels of CT1 are found in epithelia.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
Our results suggest that de novo synthesis of Cr by AGAT and GAMT, as well as cellular Cr uptake by CT1, are essential during embryonic development. This work provides new clues on how creatine can be provided to developing tissues, and suggests that Cr deficiencies might induce irreversible damages already in utero, particularly on the nervous system.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 162 163 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 164 165 164 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 295 296 295 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 297 298 297 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 393 394 393 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 395 396 395 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 59 67 <span type="species:ncbi:9606">patients</span>
###xml 197 205 <span type="species:ncbi:9606">patients</span>
Central nervous system (CNS) is the main organ affected in patients suffering from creatine (Cr) deficiency syndromes due either to AGAT, GAMT or CT1 deficiency [1-3]. As recently described, these patients present neurological symptoms in early infancy and show severe neurodevelopmental delay [4-6]. All three deficiencies are characterized by an absence, or a severe decrease, of Cr in CNS [7,8].
###end p 9
###begin p 10
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 424 425 424 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 776 778 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 844 846 844 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 933 935 933 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 936 938 936 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1077 1079 1077 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1080 1082 1080 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1146 1147 1146 1147 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1149 1150 1149 1150 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1232 1235 1232 1235 <sup xmlns:xlink="http://www.w3.org/1999/xlink">++ </sup>
###xml 1299 1301 1299 1301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1380 1382 1380 1382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1439 1441 1439 1441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1442 1444 1442 1444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1573 1574 1573 1574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1575 1576 1575 1576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1712 1714 1712 1714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1904 1906 1904 1906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1563 1571 <span type="species:ncbi:9606">patients</span>
###xml 1783 1791 <span type="species:ncbi:9606">patients</span>
The Cr / phosphocreatine (P-Cr) / creatine kinase (CK) system is essential for the buffering and transport of high energy phosphates [9]. Cr is taken up by food, or synthesized endogenously by a two-step mechanism involving L-arginine:glycine amidinotransferase (AGAT) and S-adenosyl-L-methionine:N-guanidinoacetate methyltransferase (GAMT). Cr is taken up by cells through CT1, a specific Cr transporter belonging to the Na+-dependent neurotransmitter transporter family. In adult mammals, AGAT is predominantly expressed in kidney and pancreas, and GAMT is mainly localized in liver and pancreas. In addition, both enzymes are also expressed in various other tissues, albeit at lower levels. The highest expression of CT1 is found in kidney, heart and skeletal muscle (see [10] and references therein). Cr synthesis has been observed in CNS [11]. AGAT and GAMT mRNAs have been revealed in neurons, astrocytes and oligodendrocytes [12,13]. By contrast, CT1 has been found in neurons, oligodendrocytes and microcapillary endothelial cells, but is not detectable in astrocytes [13-18]. Cr plays an essential role in CNS, where it is involved in Na+-K+-ATPase activity, neurotransmitter release, maintenance of membrane potentials, Ca++ homeostasis or restoration of ion gradients (for a review, see [10]). We have further shown recently that Cr might be involved in axonal growth [19]. Cr poorly crosses the blood brain barrier of rodents [20,21]; high doses of Cr given over a long period of treatment only partially replenish brain Cr of AGAT and GAMT deficient patients [7,8]. It has thus been suggested that the postnatal and adult CNS might depend, at least for a part of its needs, on its own Cr synthesis [13]. This is however in contradiction with the fact that CT1 deficient patients, who should express AGAT and GAMT correctly in their CNS, are nevertheless depleted in intracerebral Cr stores [22].
###end p 10
###begin p 11
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 158 163 <span type="species:ncbi:10090">mouse</span>
###xml 215 218 <span type="species:ncbi:10116">rat</span>
###xml 643 646 <span type="species:ncbi:10116">rat</span>
Little information is available on AGAT, GAMT and CT1 in embryonic development. AGAT (mRNA) and GAMT (protein) were found in whole extracts of the developing mouse embryo [23,24]. CT1 mRNA has been shown in the E14 rat embryo, in the entire neuraxis as well as in non-neural tissue [15]. The materno-fetal transport of Cr has been demonstrated [25,26]. As Cr deficiencies lead to severe developmental delay, our aim was to investigate at what time and in which tissues the system for Cr synthesis and transport is expressed during embryonic development. We determined therefore the tissue distribution of AGAT, GAMT and CT1 gene expression in rat embryos aged of 12.5, 15.5 and 18.5 days, at mRNA and protein level using in situ hybridization and immunohistochemistry respectively.
###end p 11
###begin title 12
Results
###end title 12
###begin p 13
###xml 226 227 226 227 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
###xml 301 302 301 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 305 307 305 307 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ii</bold>
###xml 365 366 365 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 382 385 382 385 <bold xmlns:xlink="http://www.w3.org/1999/xlink">iii</bold>
###xml 518 519 518 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 524 525 524 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 545 546 545 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 551 552 551 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 572 573 572 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 578 579 578 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 629 630 629 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 634 635 634 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 704 705 704 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 96 99 <span type="species:ncbi:10116">rat</span>
The developmental expression of AGAT, GAMT and CT1 genes was analyzed in E12.5, E15.5 and E18.5 rat embryos at the mRNA and protein levels. For each embryonic stage, patterns of AGAT, GAMT and CT1 expression were validated by i) the specificity of anti-AGAT, anti-GAMT and anti-CT1 antibodies (Figure 1), ii) the specificity of in situ hybridization probes (Figure 3 and [13]), and iii) the remarkable coherence between in situ hybridization (mRNA, blue) and immunohistochemistry (protein, red) stainings (see Figures 3 and 4 for E12.5, Figures 5 and 6 for E15.5, Figures 7 and 8 for E18.5). Brain structures enlarged in Figures 3 to 8 (neocortical epithelium, choroids plexus) are illustrated in Figure 2 at lower magnification.
###end p 13
###begin p 14
###xml 0 63 0 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Specificity of the anti-AGAT, anti-GAMT and anti-CT1 antibodies</bold>
###xml 108 111 <span type="species:ncbi:10116">rat</span>
Specificity of the anti-AGAT, anti-GAMT and anti-CT1 antibodies. Western blot analysis of cell extract from rat kidney, by anti-AGAT, anti-GAMT and anti-CT1 antibodies. 10 mug of proteins were loaded in each lane. MM is the molecular mass marker.
###end p 14
###begin p 15
###xml 0 53 0 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Neocortex of the rat embryo at E12.5, E15.5 and E18.5</bold>
###xml 77 78 77 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 87 88 87 88 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 97 98 97 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 175 176 175 176 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 178 180 178 180 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B </bold>
###xml 184 186 184 186 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C </bold>
###xml 274 276 274 276 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CP</bold>
###xml 294 296 294 296 <bold xmlns:xlink="http://www.w3.org/1999/xlink">LV</bold>
###xml 317 318 317 318 <bold xmlns:xlink="http://www.w3.org/1999/xlink">N</bold>
###xml 331 332 331 332 <bold xmlns:xlink="http://www.w3.org/1999/xlink">P</bold>
###xml 17 20 <span type="species:ncbi:10116">rat</span>
Neocortex of the rat embryo at E12.5, E15.5 and E18.5. Hematoxylin staining. A: E12.5. B: E15.5. C: E18.5. Neocortical and plexus choroid structures depicted by rectangles in A, B and C are enlarged in Figures 3 A,E,I; 4 B,E,H; 5 A,B,F,G,K,L; 6 A,E,I; 7 A,B,M,N; and 8 A,B. CP: choroid plexus; LV: lateral ventricle; N: neocortex; P: pallidum. Bar : 200 mum.
###end p 15
###begin p 16
###xml 0 66 0 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of the AGAT, GAMT and CT1 mRNAs in the E12.5 rat embryo</bold>
###xml 168 171 168 171 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-C</bold>
###xml 180 183 180 183 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E-G</bold>
###xml 194 197 194 197 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I-K</bold>
###xml 254 255 254 255 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 264 265 264 265 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H</bold>
###xml 276 277 276 277 <bold xmlns:xlink="http://www.w3.org/1999/xlink">L</bold>
###xml 280 286 280 286 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A,E,I </bold>
###xml 290 295 290 295 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D,H,L</bold>
###xml 335 340 335 340 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B,F,J</bold>
###xml 351 356 351 356 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C,G,K</bold>
###xml 56 59 <span type="species:ncbi:10116">rat</span>
Expression of the AGAT, GAMT and CT1 mRNAs in the E12.5 rat embryo. In situ hybridization (mRNA, blue signal) experiments performed with antisense probes against AGAT (A-C), GAMT (E-G) and CT1 (I-K) mRNAs, and with the sense counterpart probes for AGAT (D), GAMT (H) and CT1 (L). A,E,I and D,H,L: dorsal telencephalic neuroepithelium; B,F,J: somites; C,G,K: liver. Bar : 100 mum.
###end p 16
###begin p 17
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of the AGAT, GAMT and CT1 proteins in the E12.5 rat embryo</bold>
###xml 152 155 152 155 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-C</bold>
###xml 169 172 169 172 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D-F</bold>
###xml 188 191 188 191 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G-I</bold>
###xml 205 211 205 211 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A,D,G </bold>
###xml 248 253 248 253 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B,E,H</bold>
###xml 293 298 293 298 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C,F,I</bold>
###xml 313 318 313 318 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A,D,G</bold>
###xml 329 340 328 339 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B,C,E,F,H,I</bold>
###xml 59 62 <span type="species:ncbi:10116">rat</span>
Expression of the AGAT, GAMT and CT1 proteins in the E12.5 rat embryo. Immunohistochemistry (protein, red signal) experiments performed with anti-AGAT (A-C), anti-GAMT (D-F) and anti-CT1 (G-I) antibodies. A,D,G : coronal section through hindbrain; B,E,H: dorsal telencephalic neuroepithelium; C,F,I: liver. Bar : A,D,G: 200 mum; B,C,E,F,H,I: 100 mum.
###end p 17
###begin p 18
###xml 0 66 0 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of the AGAT, GAMT and CT1 mRNAs in the E15.5 rat embryo</bold>
###xml 168 171 168 171 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-E</bold>
###xml 180 183 180 183 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F-J</bold>
###xml 194 197 194 197 <bold xmlns:xlink="http://www.w3.org/1999/xlink">K-O</bold>
###xml 206 211 206 211 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A,F,K</bold>
###xml 242 247 242 247 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B,G,L</bold>
###xml 265 270 265 270 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C,H,M</bold>
###xml 292 297 292 297 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D,I,N</bold>
###xml 307 312 307 312 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E,J,O</bold>
###xml 56 59 <span type="species:ncbi:10116">rat</span>
Expression of the AGAT, GAMT and CT1 mRNAs in the E15.5 rat embryo. In situ hybridization (mRNA, blue signal) experiments performed with antisense probes against AGAT (A-E), GAMT (F-J) and CT1 (K-O) mRNAs. A,F,K: neocortical neuroepithelium; B,G,L: choroid plexus; C,H,M: gonadal primordium; D,I,N: kidney; E,J,O: liver. Bar : 100 mum.
###end p 18
###begin p 19
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of the AGAT, GAMT and CT1 proteins in the E15.5 rat embryo</bold>
###xml 152 155 152 155 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-D</bold>
###xml 169 172 169 172 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E-H</bold>
###xml 188 191 188 191 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I-L</bold>
###xml 205 210 205 210 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A,E,I</bold>
###xml 241 246 241 246 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B,F,J</bold>
###xml 268 273 268 273 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C,G,L</bold>
###xml 283 288 283 288 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D,H,L</bold>
###xml 59 62 <span type="species:ncbi:10116">rat</span>
Expression of the AGAT, GAMT and CT1 proteins in the E15.5 rat embryo. Immunohistochemistry (protein, red signal) experiments performed with anti-AGAT (A-D), anti-GAMT (E-H) and anti-CT1 (I-L) antibodies. A,E,I: neocortical neuroepithelium; B,F,J: gonadal primordium; C,G,L: kidney; D,H,L: liver. Bar : 100 mum.
###end p 19
###begin p 20
###xml 0 51 0 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of AGAT and GAMT in the E18.5 rat embryo</bold>
###xml 168 171 168 171 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-L</bold>
###xml 183 186 183 186 <bold xmlns:xlink="http://www.w3.org/1999/xlink">M-X</bold>
###xml 189 196 189 196 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A,B,M,N</bold>
###xml 227 234 227 234 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C,D,O,P</bold>
###xml 253 260 253 260 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E,F,Q,R</bold>
###xml 270 277 270 277 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G,H,S,T</bold>
###xml 286 293 286 293 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I,J,U,V</bold>
###xml 305 312 305 312 <bold xmlns:xlink="http://www.w3.org/1999/xlink">K,L,W,X</bold>
###xml 41 44 <span type="species:ncbi:10116">rat</span>
Expression of AGAT and GAMT in the E18.5 rat embryo. In situ hybridization (mRNA, blue signal) and immunohistochemistry (protein, red signal) experiments against AGAT (A-L) and GAMT (M-X). A,B,M,N: neocortical neuroepithelium; C,D,O,P: skeletal muscle; E,F,Q,R: kidney; G,H,S,T: liver; I,J,U,V: pancreas; K,L,W,X: intestine. Bar : 100 mum.
###end p 20
###begin p 21
###xml 0 41 0 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of CT1 in the E18.5 rat embryo</bold>
###xml 157 160 157 160 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A,B</bold>
###xml 191 194 191 194 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C,D</bold>
###xml 202 205 202 205 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E,F</bold>
###xml 215 218 215 218 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G,H</bold>
###xml 31 34 <span type="species:ncbi:10116">rat</span>
Expression of CT1 in the E18.5 rat embryo. In situ hybridization (mRNA, blue signal) and immunohistochemistry (protein, red signal) experiments against CT1. A,B: neocortical neuroepithelium; C,D: skin; E,F: kidney; G,H: intestine. Bar : 100 mum.
###end p 21
###begin p 22
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of AGAT mRNA in the main tissues of the rat embryo.</bold>
###xml 51 54 <span type="species:ncbi:10116">rat</span>
Expression of AGAT mRNA in the main tissues of the rat embryo. i : isolated cells ; - : absent ; +/- : barely detectable ; + : moderate expression, ++ : strong expression, +++ : very strong expression. More differentiated structures of older stages are connected with the "{" sign to the younger structure from which they originate. 
###end p 22
###begin p 23
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of GAMT mRNA in the main tissues of the rat embryo.</bold>
###xml 51 54 <span type="species:ncbi:10116">rat</span>
Expression of GAMT mRNA in the main tissues of the rat embryo. i : isolated cells ; - : absent ; +/- : barely detectable ; + : moderate expression, ++ : strong expression, +++ : very strong expression. More differentiated structures of older stages are connected with the "{" sign to the younger structure from which they originate. 
###end p 23
###begin p 24
###xml 0 61 0 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of CT1 mRNA in the main tissues of the rat embryo.</bold>
###xml 50 53 <span type="species:ncbi:10116">rat</span>
Expression of CT1 mRNA in the main tissues of the rat embryo. i : isolated cells ; - : absent ; +/- : barely detectable ; + : moderate expression, ++ : strong expression, +++ : very strong expression. More differentiated structures of older stages are connected with the "{" sign to the younger structure from which they originate.
###end p 24
###begin title 25
###xml 6 9 <span type="species:ncbi:10116">rat</span>
E12.5 rat embryos
###end title 25
###begin p 26
###xml 75 76 75 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 334 335 334 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
AGAT was detected in all parts of the E12.5 central nervous system (Figure 9; Figures 3A; 4A and 4B). Highest levels were detected in the middle part of somites (Figure 3B) as well as in the hepatic primordium (Figures 3C; 4C). AGAT was also detected in the wall of dorsal aorta, but was not detectable in epidermis and heart (Figure 9).
###end p 26
###begin p 27
###xml 69 71 69 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3G</xref>
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4F</xref>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
###xml 136 140 136 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3E&#8211;F</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D</xref>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4E</xref>
GAMT at E12.5 was detectable in the hepatic primordium only (Figures 3G; 4F), with all other tissues being negative (Figure 10, Figures 3E-F; 4D and 4E).
###end p 27
###begin p 28
###xml 56 58 56 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11</xref>
###xml 68 70 68 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3I</xref>
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4G</xref>
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4E</xref>
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3J</xref>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3K</xref>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4I</xref>
###xml 373 375 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11</xref>
CT1 was expressed by all parts of the E12.5 CNS (Figure 11; Figures 3I; 4G and 4E). In contrast to AGAT which was restricted to the central part of somites, CT1 was found expressed throughout the whole somites (Figure 3J). CT1 was also present in the dorsal aorta and the hepatic primordium (Figures 3K; 4I). At E12.5, CT1 was not detectable in epidermis and heart (Figure 11).
###end p 28
###begin p 29
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3H</xref>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3L</xref>
In situ hybridization control sections hybridized with the respective AGAT, GAMT and CT1 sense probes were negative (Figure 3D, 3H and 3L).
###end p 29
###begin title 30
###xml 6 9 <span type="species:ncbi:10116">rat</span>
E15.5 rat embryos
###end title 30
###begin p 31
###xml 142 143 142 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 254 255 254 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5E</xref>
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D</xref>
###xml 531 532 531 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 591 593 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 650 651 650 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
AGAT was expressed in most regions of the E15.5 CNS, with increased levels detected in isolated cells throughout the developing brain (Figure 9; Figures 5A; 6A). AGAT was not detected in choroid plexus (Figure 5B), nor in the dorsal root ganglia (Figure 9). High levels of AGAT were observed in skeletal muscles and primordia of gonads (Figures 5C; 6B), and AGAT was also detected in caudal somites (as shown earlier at E12.5, Fig. 3B), liver (Figures 5E; 6D) and pancreas, with, as in CNS, higher levels in isolated cells (Figure 9). At E15.5, AGAT could not be detected in kidney (Figures 5D; 6C), nor in all the remaining tissues observed (Figure 9).
###end p 31
###begin p 32
###xml 61 63 61 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5F</xref>
###xml 65 67 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6E</xref>
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5J</xref>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6H</xref>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
GAMT could not be detected in most of the E15.5 CNS (Figures 5F; 6E), with the exception of striatum and pons (Figure 10). High levels of GAMT were found in liver (Figures 5J; 6H), and it was also expressed in pancreas. All the remaining tissues observed were negative for GAMT at E15.5 (Figure 10).
###end p 32
###begin p 33
###xml 60 62 60 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11</xref>
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5K</xref>
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6I</xref>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5L</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5N</xref>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6K</xref>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11</xref>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5M</xref>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6J</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5O</xref>
###xml 356 358 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6L</xref>
###xml 424 426 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11</xref>
CT1 was strongly expressed in most of the E15.5 CNS (Figure 11; Figures 5K; 6I). CT1 was detected in choroid plexus (Figure 5L). CT1 was observed in skeletal muscles and caudal somites, as well as in kidney (Figures 5N; 6K), lung, stomach and intestine epithelial cells (Figure 11). CT1 could not be detected in gonads (Figures 5M; 6J), liver (Figures 5O; 6L) and pancreas, nor in all the remaining tissues observed (Figure 11).
###end p 33
###begin title 34
###xml 6 9 <span type="species:ncbi:10116">rat</span>
E18.5 rat embryos
###end title 34
###begin p 35
###xml 65 66 65 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 239 240 239 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 352 356 352 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7C,D</xref>
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7E,F</xref>
###xml 401 405 401 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7I,J</xref>
###xml 463 467 463 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7G,H</xref>
###xml 508 512 508 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7K,L</xref>
###xml 653 654 653 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
AGAT mRNA was expressed in most regions of the E18.5 CNS (Figure 9). Interestingly, high levels of AGAT mRNA were detected in endothelial cells of the developing cerebral capillaries (Figure 7A), but was absent from choroid plexus (Figure 9). A high expression of AGAT, both at the mRNA and protein levels, was also detected in skeletal muscle (Figure 7C,D), kidney (Figure 7E,F) and pancreas (Figure 7I,J), while a lower level of AGAT was found in liver (Figure 7G,H) and intestine epithelial cells (Figure 7K,L). At E18.5, AGAT could not be detected in epidermis and dermis, in olfactory epithelium, trachea and lung, nor in stomach and heart (Figure 9).
###end p 35
###begin p 36
###xml 40 44 40 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7M,N</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
###xml 400 404 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7O,P</xref>
###xml 424 428 424 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7S,T</xref>
###xml 477 481 477 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7U,V</xref>
###xml 523 527 523 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7W,X</xref>
###xml 585 589 585 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7Q,R</xref>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
GAMT was expressed in neocortex (Figure 7M,N), hippocampus, striatum, pallidum and spinal cord, but could not be detected in other structures of the E18.5 brain (Figure 10). GAMT was absent from endothelial cells of cerebral capillaries, as well as from choroid plexus. In peripheral tissues, the highest expression of GAMT, both at the mRNA and protein levels, was found in skeletal muscles (Figure 7O,P) and liver (Figure 7S,T), while it was also present in pancreas (Figure 7U,V) and intestinal epithelial cells (Figure 7W,X). GAMT could not be detected in the E18.5 kidney (Figure 7Q,R), nor in all the remaining tissues observed (Figure 10).
###end p 36
###begin p 37
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11</xref>
###xml 114 118 114 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A,B</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11</xref>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11</xref>
###xml 335 339 335 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8C,D</xref>
###xml 357 361 357 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8E,F</xref>
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8G,H</xref>
###xml 484 486 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11</xref>
CT1 was highly expressed in most regions of the E18.5 CNS, both at the mRNA and protein levels (Figure 11, Figure 8A,B). CT1 was absent from endothelial cells of cerebral capillaries, but highly expressed in choroid plexus (Figure 11). Most peripheral tissues expressed CT1 (Figure 11), as illustrated for epidermis and dermis (Figure 8C,D), kidney (Figure 8E,F) and intestine epithelial cells (Figure 8G,H). However, no signal for CT1 could be detected in liver and pancreas (Figure 11).
###end p 37
###begin title 38
Discussion
###end title 38
###begin title 39
Creatine in embryonic development
###end title 39
###begin p 40
###xml 190 191 190 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 557 559 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 680 682 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 683 685 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 686 688 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 854 856 854 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 364 367 <span type="species:ncbi:10116">rat</span>
###xml 497 500 <span type="species:ncbi:10116">rat</span>
###xml 505 510 <span type="species:ncbi:9606">human</span>
###xml 706 710 <span type="species:ncbi:10090">mice</span>
###xml 779 784 <span type="species:ncbi:9606">human</span>
###xml 800 808 <span type="species:ncbi:9606">patients</span>
The Cr / P-Cr / CK system plays an essential role in energy homeostasis during the vertebrate embryonic development, with prominent activities in tissues such as developing CNS and muscles [9]. CK genes are expressed very early in many structures of the vertebrate embryo [27,28], whereas Cr concentration between 2 and 4 mmol/kg wet weight are found in the whole rat fetus, depending on the developmental stage [29]. In CNS, Cr concentration between 5 and 8 mmol/kg wet weight have been found in rat and human fetus, depending on the gestational stage [29,30]. Parts of the developmental needs for Cr can be fulfilled by the active transport of Cr from the mother to the embryo [25,26,31]. GAMT knock-out mice, which develop biochemical alterations comparable to those found in human GAMT deficient patients, present an increase in perinatal mortality [24]. It is not known however whether alterations in Cr pathways, as found in AGAT, GAMT or CT1 deficiencies, impairs the development of the embryo.
###end p 40
###begin title 41
AGAT and GAMT for de novo synthesis of Cr in the embryo
###end title 41
###begin p 42
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 570 572 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1486 1488 1486 1488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1489 1491 1489 1491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1492 1494 1492 1494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1581 1583 1581 1583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1584 1586 1584 1586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 222 225 <span type="species:ncbi:10116">rat</span>
As both substrates arginine (for AGAT) and S-adenosylmethionine (for GAMT) are available for most tissues (including liver, brain and muscle) during the mammalian embryonic development [32-34], our study suggests that the rat embryo might be able of its own Cr synthesis as soon as E12.5, in the hepatic primordium which expresses both AGAT and GAMT. From E12.5 to E18.5, both enzymes then progressively acquire their expression pattern found in aduldhood, with AGAT mainly expressed in kidney and pancreas, and GAMT preferentially localized in liver and pancreas (see [10] and references therein). As in adulthood however, many other different embryonic tissues retain low levels of AGAT and/or GAMT; we found that skeletal muscles and intestinal epithelial cells at E18.5 are equipped to synthesize their own Cr by expressing both AGAT and GAMT. A few embryonic structures express only AGAT (muscles before E18.5, regions of CNS, blood vessels) suggesting that they have to release the intermediate GAA, that has to be transported to GAMT-expressing cells for Cr synthesis to occur, as it is generally thought between kidney (AGAT) and liver (GAMT) in adult mammals. A few embryonic structures (i.e. somites at E12.5 and E15.5, skeletal muscles at E15.5 and E18.5, gonadal primordium at E15.5) showed a striking and very high expression of AGAT. This might be explained by the strong and positive regulation of AGAT, at the transcriptional level, by thyroid, growth and sex hormones [26,35,36], which do control the embryonic development of somites, skeletal muscles and gonads [37-40].
###end p 42
###begin p 43
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 249 252 <span type="species:ncbi:10116">rat</span>
While this study shows that AGAT is expressed as soon as E12.5 in the whole CNS parenchyme and increases towards E18.5, it demonstrates also that GAMT expression in the developing CNS is delayed, and remains at low levels as compared to AGAT. Adult rat CNS appears to be able of synthesizing its own Cr by expressing AGAT and GAMT in most cell types of the brain [13]; in contrast, our work suggests that independance of CNS for its own Cr synthesis is probably limited to the end of embryogenesis and restricted to discrete regions of CNS. Thus, the embryonic brain might depend mainly on extra-CNS supply of Cr, be it of maternal origin or synthesized in other tissues of the embryo (see below).
###end p 43
###begin title 44
CT1 for the supply of Cr to embryonic tissues
###end title 44
###begin p 45
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 689 691 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 859 861 859 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 976 978 976 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 340 343 <span type="species:ncbi:10116">rat</span>
From E12.5 to E18.5, most of the embryonic tissues progressively express CT1, allowing cellular Cr uptake. Notable exceptions are liver (apart from a low and transient expression at E12.5) and pancreas, which express GAMT, and endothelial cells of brain capillaries (see below). These results are in accordance with earlier work on the E14 rat embryo [15]. Highest levels of CT1 are found as soon as E12.5, in tissues requiring high amounts of Cr, like somites, skeletal muscles and CNS. In gonads, CT1 and GAMT appeared at E18.5 only, while AGAT was highly expressed at E15.5 and decreased at E18.5. This is in accordance with their respective expression in the adult reproductive tract [12,41]. CT2, a second potential Cr transporter showing 95% nucleotide identity with the CT1 coding sequence, has been found expressed in testis solely, at the RNA level [41]. However, CT2 most probably represents a pseudogene, as it cannot be fully translated into a functional protein [42], suggesting that the needs in Cr of the reproductive tract are fulfilled by CT1, as well as AGAT and GAMT.
###end p 45
###begin p 46
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 534 536 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 537 539 537 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 659 661 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 920 922 920 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1302 1304 1302 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1305 1307 1305 1307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1557 1559 1557 1559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1560 1562 1560 1562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1796 1798 1796 1798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 330 333 <span type="species:ncbi:10116">rat</span>
###xml 381 384 <span type="species:ncbi:10116">rat</span>
###xml 525 528 <span type="species:ncbi:10116">rat</span>
The delayed and low level of GAMT expression during CNS embryogenesis suggests that the embryonic brain might depend on extra-CNS supply of Cr. This is supported by our results on CT1, which is expressed at high levels in the whole embryonic CNS, with a peak at E15.5. Interestingly, CT1 is expressed in the choroid plexus of the rat embryo (E15.5 and E18.5), but not of the adult rat brain [13]. In contrast, CT1 is absent from endothelial cells of brain capillaries in the embryo, while these cells express it in the adult rat CNS [13,20]. As choroid plexus differentiates earlier than brain capillaries and participates to early trophic supply for CNS [43,44], one might speculate that before angiogenesis occurs in CNS parenchyme, extra-CNS Cr is supplied from blood to cerebrospinal fluid through the choroid plexus. Cr would then be available for the whole embryonic brain through cerebrospinal fluid circulation [45] and the observed high levels of CT1 in the developing neuroepithelium, particularly in ependymal epithelium along ventricles (see below CT1 in surface epithelia exposed to amniotic fluid). As brain develops and enlarges, and CNS angiogenesis progresses, the ratio of exchange surfaces in choroid plexus and CNS microcapillaries shifts to predominance of brain microcapillaries [43-45]. Thus, at the end of embryonic development and then postnatally, Cr supply to the brain may occur preferentially at microcapillaries, with CT1 being up-regulated in capillary endothelial cells and down-regulated in choroid plexus, as in adulthood [13,20]. It should be emphasized however that supply of Cr from blood to postnatal or adult brain is very likely of less quantitative importance than intra-cerebral Cr synthesis, as astrocytes around blood brain barrier do not express CT1 [13].
###end p 46
###begin p 47
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 377 379 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 398 400 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 75 78 <span type="species:ncbi:10116">rat</span>
###xml 246 249 <span type="species:ncbi:10116">rat</span>
###xml 341 346 <span type="species:ncbi:9606">human</span>
###xml 393 396 <span type="species:ncbi:10116">rat</span>
At E15.5 and E18.5, CT1 was found highly expressed in all epithelia of the rat embryo being in contact with amniotic fluid, i.e. epidermis, olfactory epithelium, trachea, lung, stomach, and intestine. Cr uptake has been confirmed recently in E16 rat embryo intestine [46]. Amniotic fluid contains significant amounts of Cr (50 to 100 muM in human depending on gestational age [47]; 320 muM in rat [46]). It is produced by amniotic cells (at the surface of chorion) and the foetus, and is continuously renewed by oral intake of the foetus and excretion (urine). Amniotic fluid may thus represent an easy way to supply Cr to many structures of the embryo, through epithelial expression of CT1 in embryonic parts where vasculature is not yet fully developed.
###end p 47
###begin p 48
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
It is known that Cr is also supplied by active transport from the mother to the embryo, accumulating in the chorioallantoic placenta and yolk sac at concentrations higher than found in maternal or fetal blood, then diffusing down its concentration gradient into the fetal circulation [25,26,31]. Thus previous studies, as well as our data, suggest that materno-fetal transport of Cr and de novo synthesis of Cr in the embryo are both necessary for a normal development to occur.
###end p 48
###begin title 49
In utero consequences of AGAT, GAMT or CT1 deficiencies
###end title 49
###begin p 50
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 248 249 248 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 250 251 250 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 252 253 252 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 516 517 516 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 518 519 518 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 289 297 <span type="species:ncbi:9606">patients</span>
###xml 429 437 <span type="species:ncbi:9606">patients</span>
###xml 612 620 <span type="species:ncbi:9606">patients</span>
###xml 803 806 <span type="species:ncbi:10116">rat</span>
###xml 893 901 <span type="species:ncbi:9606">patients</span>
Patients suffering of AGAT, GAMT or CT1 deficiency present neurological symptoms in early infancy and show severe neurodevelopmental delay [7,22]. AGAT and GAMT deficiencies can be treated with oral Cr, which slowly replenishes brain levels of Cr [1,3-5,48-50]. Treatment of CT1 deficient patients with oral Cr does not replenish their CNS Cr level [51]. Despite developmental improvement and recovery of AGAT and GAMT deficient patients treated with Cr, sequelae to brain development and mental retardation remain [7,8]. For GAMT deficiency, this may be due to the toxicity of the GAA accumulating in CNS. Most patients with AGAT, GAMT or CT1 deficiencies are diagnosed during infancy, and significant damage to their brain occur postnatally. However, AGAT, GAMT and CT1 expression patterns during the rat embryogenesis suggests that some of the irreversible damages observed in Cr deficient patients, lacking either AGAT, GAMT or CT1, may already occur in utero.
###end p 50
###begin title 51
Conclusion
###end title 51
###begin p 52
###xml 105 108 <span type="species:ncbi:10116">rat</span>
###xml 377 385 <span type="species:ncbi:9606">patients</span>
We have shown that AGAT, GAMT and CT1 are expressed by various tissues throughout the development of the rat embryo. This study suggests that de novo synthesis of Cr and Cr uptake are important for embryonic development. This work provides new clues on how creatine can be provided to developing tissues, and suggests moreover that irreversible damage observed in Cr deficient patients, lacking either AGAT, GAMT or CT1, may already occur in utero.
###end p 52
###begin title 53
Methods
###end title 53
###begin title 54
###xml 38 41 <span type="species:ncbi:10116">rat</span>
Preparation of E12.5, E15.5 and E18.5 rat embryos
###end title 54
###begin p 55
###xml 133 137 <span type="species:ncbi:10116">rats</span>
###xml 229 232 <span type="species:ncbi:10116">rat</span>
All animal procedures were in compliance with the directives of the Swiss Academy of Medical Science. Sprague-Dawley pregnant female rats (Charles River Laboratories, France) were fed a standard chow formula. Embryonic stages of rat embryos were determined from the appearance of vaginal plug in pregnant females. 2 pregnant females were used for each embryonic stage (E12.5: 12.5 days of gestation, 7 embryos; E15.5: 15.5 days of gestation, 5 embryos; E18.5: 18.5 days of gestation, 5 embryos). For each embryonic stage, females were sacrificed by decapitation, and embryos were removed from uterus, rinsed in diethylpyrocarbonate (DEPC)-treated PBS and fixed for 15 h at room temperature in 4% paraformaldehyde in DEPC-treated PBS. Subsequently, embryos were cryoprotected at 4degreesC in 12% and 18% sucrose in DEPC-treated PBS for 18 h and 24 h respectively, then embedded in tissue-freezing medium (Jung, Nussloch, Germany) and frozen in liquid nitrogen cooled isopentane. Embryos were stored at -80degreesC until used for cryosections.
###end p 55
###begin title 56
In situ hybridization and immunohistochemistry
###end title 56
###begin p 57
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 441 443 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 21 24 <span type="species:ncbi:10116">rat</span>
###xml 802 805 <span type="species:ncbi:10116">rat</span>
Partial cDNAs of the rat sequences AGAT (nt 182-1314, Gene Bank accession number ), GAMT (nt 131-734, Gene Bank ) and CT1 (nt 901-2544, Gene Bank ) were used to synthesize antisense and sense digoxigenin-labeled AGAT, GAMT and CT1 riboprobes as described previously [13]. 12 mum thick cryosections (Leica CM 1800) were prepared for each embryonic stage, which were analyzed by a sensitive technique of non-radioactive in situ hybridization [52]. Briefly, cryosections were postfixed 10 min in 4% paraformaldehyde in DEPC-treated PBS, washed 2 x 15 min in PBS containing 0.1% fresh DEPC and equilibrated 15 min in 5 x SSC. Sections were hybridized (58degreesC for 40 h in 5 x SSC, 50% formamide and 40 mug/ml salmon sperm DNA) with the digoxigenin-labeled antisense and sense riboprobes (400 ng/ml) for rat AGAT, GAMT and CT1. Sections were then washed (30 min in 2 x SSC at room temperature, 1 h in 2 x SSC at 65degreesC, 1 h in 0.1 x SSC at 65degreesC) and stained with alkaline phosphatase-coupled anti-digoxygenin antibody (Roche, Basel, Switzerland) using nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl-phosphate. The specificity of hybridization was ascertained by the use of sense probes for AGAT, GAMT and CT1 genes having the same length, GC content and digoxigenin incorporation as their antisense counterparts. In each in situ hybridization experiment, a section hybridized with an antisense probe was always followed by an adjacent section hybridized with the corresponding sense control probe. After staining, sections were dehydrated and mounted (Eukit, O. Kindler Co, Freiburg, Germany).
###end p 57
###begin p 58
###xml 597 598 597 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 867 868 866 867 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 869 871 868 870 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1191 1192 1190 1191 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1193 1194 1192 1193 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 47 53 <span type="species:ncbi:9986">rabbit</span>
###xml 915 921 <span type="species:ncbi:9913">bovine</span>
AGAT, GAMT and CT1 proteins were detected with rabbit polyclonal antibodies, that were made through injection of the following antigenic peptides: AGAT N-terminal amino acids (aa) 62-77 and C-terminal aa 410-423(SwissProt, accession number ); GAMT aa 27-227(SwissProt, accession number ); and CT1 N-terminal aa 15-29 (SwissProt, accession number ). Specific immunoglobulins against AGAT, GAMT and CT1 were obtained by peptide affinity chromatography. These antibodies recognize specific bands for AGAT (46 kDa), GAMT (26 kDa) and CT1 (61 kDa) respectively, by western blotting experiments (Figure 1). AGAT, GAMT and CT1 proteins were analyzed by immunohistochemistry on 8 mum thick cryosections using the 3 polyclonal antibodies described above. Briefly, cryosections were postfixed for 1 h in 4%PFA in PBS. Endogenous peroxidase activities were bleached using 1.5% H2O2 in PBS for 15 min. After blocking 1 h in 1% bovine serum albumin in PBS, anti-AGAT, anti-GAMT and anti-CT1 antibodies were incubated for 1 h at room temperature in the same buffer. Their detection by peroxidase staining was performed using the Histostain Plus Kit (Zymed Laboratories Inc) with aminoethyl carbazole and H2O2.
###end p 58
###begin p 59
###xml 137 138 137 138 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
###xml 334 336 334 336 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ii</bold>
###xml 424 425 424 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 442 445 442 445 <bold xmlns:xlink="http://www.w3.org/1999/xlink">iii</bold>
The expression patterns of AGAT, GAMT and CT1 genes observed during the embryonic development were considered specific and validated by (i) the excellent correlation, in the multiple embryonic tissues analysed, between the signals observed at the mRNA level by in situ hybridization and at the protein level by immunohistochemistry, (ii) the negative signals observed with the in situ hybridization sense probes (see Figure 3 and [13]), and (iii) by the absence of any labelling in immunohistochemical controls without primary antibodies or in presence of pre-immune serum (data not shown).
###end p 59
###begin p 60
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 237 238 237 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 252 253 252 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11</xref>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
Sections were observed and photographed on an Olympus BX50 microscope equipped with a DP-10 digital camera (Olympus Opticals, Japan). Structures were identified according to [53-55], after staining of sections by hematoxylin (see Figure 2). In Figures 9,10 and 11 semi-quantitative levels of AGAT, GAMT and CT1 mRNA were determined based on ISH experiments, as described [56]. Levels of transcripts observed by optical microscopy are indicated by - and + signs which however do not represent a strict linear mesure of mRNA.
###end p 60
###begin title 61
List of abbreviations used
###end title 61
###begin p 62
AGAT: arginine:glycine amidinotransferase; CK: creatine kinase; CNS: central nervous system; Cr: creatine; CT1: creatine transporter 1; DEPC: diethylpyrocarbonate; GAMT: guanidinoacetate methyltransferase; P-Cr: phosphocreatine
###end p 62
###begin title 63
Authors' contributions
###end title 63
###begin p 64
###xml 259 262 <span type="species:ncbi:11866?0.5863095238095238|species:ncbi:12321?0.21726190476190477">AMV</span>
OB conceived of the study, wrote the manuscript and performed immunohistochemistry experiments. HH designed and characterized the anti-GAMT and anti-CT1 antibodies, performed the western blotting experiments and participated in the writing of the manuscript. AMV carried out the in situ hybridization and immunohistochemistry experiments. OS designed and characterized the anti-AGAT antibody, and participated in the writing of the manuscript. TW and CB participated in the writing of the manuscript. All authors read and approved the final manuscript.
###end p 64
###begin title 65
Acknowledgements
###end title 65
###begin p 66
This work was funded by the Swiss National Science Foundation (grants ndegrees 3100-063892 and 3100A0-100778 to OB, HH and CB; ndegrees 3100A0-102075 to TW) and the Swiss Society for Research on Muscle Disease (to TW). Marc Loup and Barbara Eilers are gratefully acknowledged for their excellent technical work.
###end p 66
###begin article-title 67
Creatine deficiency in the brain: a new, treatable inborn error of metabolism
###end article-title 67
###begin article-title 68
X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome
###end article-title 68
###begin article-title 69
###xml 97 103 <span type="species:ncbi:9606">humans</span>
Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans
###end article-title 69
###begin article-title 70
Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: diagnostic tools for a new inborn error of metabolism
###end article-title 70
###begin article-title 71
Creatine depletion in a new case with AGAT deficiency: clinical and genetic study in a large pedigree
###end article-title 71
###begin article-title 72
Congenital creatine transporter deficiency
###end article-title 72
###begin article-title 73
Clinical characteristics and diagnostic clues in inborn errors of creatine metabolism
###end article-title 73
###begin article-title 74
Biochemical and clinical characteristics of creatine deficiency syndromes
###end article-title 74
###begin article-title 75
Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis
###end article-title 75
###begin article-title 76
Creatine and creatinine metabolism
###end article-title 76
###begin article-title 77
Distribution of creatine, guanidinoacetate and enzymes for their biosynthesis in the animal kingdom. Implications for phylogeny
###end article-title 77
###begin article-title 78
###xml 53 56 <span type="species:ncbi:10116">rat</span>
Creatine synthesis and transport systems in the male rat reproductive tract
###end article-title 78
###begin article-title 79
###xml 54 57 <span type="species:ncbi:10116">rat</span>
Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study
###end article-title 79
###begin article-title 80
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 40 46 <span type="species:ncbi:9986">rabbit</span>
A Na+-dependent creatine transporter in rabbit brain, muscle, heart, and kidney. cDNA cloning and functional expression
###end article-title 80
###begin article-title 81
###xml 13 16 <span type="species:ncbi:10116">rat</span>
The putative rat choline transporter CHOT1 transports creatine and is highly expressed in neural and muscle-rich tissues
###end article-title 81
###begin article-title 82
###xml 72 75 <span type="species:ncbi:10116">rat</span>
In situ hybridization analysis of CHOT1, a creatine transporter, in the rat central nervous system
###end article-title 82
###begin article-title 83
###xml 51 54 <span type="species:ncbi:10116">rat</span>
Regional distribution of a creatine transporter in rat auditory brainstem: an in situ hybridization study
###end article-title 83
###begin article-title 84
###xml 18 21 <span type="species:ncbi:10116">rat</span>
Expression of the rat brain creatine transporter in situ and in transfected HeLa cells
###end article-title 84
###begin article-title 85
Ammonium-induced impairment of axonal growth is prevented through glial creatine
###end article-title 85
###begin article-title 86
The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the brain
###end article-title 86
###begin article-title 87
###xml 79 82 <span type="species:ncbi:10116">rat</span>
Kinetics of creatine in blood and brain after intraperitoneal injection in the rat
###end article-title 87
###begin article-title 88
X-linked creatine transporter defect: an overview
###end article-title 88
###begin article-title 89
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
Gatm, a creatine synthesis enzyme, is imprinted in mouse placenta
###end article-title 89
###begin article-title 90
###xml 106 111 <span type="species:ncbi:10090">mouse</span>
Severely altered guanidino compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiency
###end article-title 90
###begin article-title 91
###xml 43 46 <span type="species:ncbi:10116">rat</span>
Materno-fetal transport of creatine in the rat
###end article-title 91
###begin article-title 92
Creatine: biosynthesis, regulation, and function
###end article-title 92
###begin article-title 93
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
###xml 103 108 <span type="species:ncbi:9031">chick</span>
Developmental regulation of creatine kinase gene expression by myogenic factors in embryonic mouse and chick skeletal muscle
###end article-title 93
###begin article-title 94
###xml 51 60 <span type="species:ncbi:7955">zebrafish</span>
Expression of brain subtype creatine kinase in the zebrafish embryo
###end article-title 94
###begin article-title 95
###xml 69 72 <span type="species:ncbi:10116">rat</span>
Developmental changes in organic osmolytes in prenatal and postnatal rat tissues
###end article-title 95
###begin article-title 96
###xml 102 103 102 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1</sup>
###xml 42 47 <span type="species:ncbi:9606">human</span>
Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopy
###end article-title 96
###begin article-title 97
###xml 39 42 <span type="species:ncbi:10116">rat</span>
Placental transport of creatine in the rat
###end article-title 97
###begin article-title 98
Arginine nutrition in development, health and disease
###end article-title 98
###begin article-title 99
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
Essential role of S-adenosylmethionine decarboxylase in mouse embryonic development
###end article-title 99
###begin article-title 100
###xml 145 150 <span type="species:ncbi:10090">mouse</span>
Deletion of the Pemt gene increases progenitor cell mitosis, DNA and protein methylation and decreases calretinin expression in embryonic day 17 mouse hippocampus
###end article-title 100
###begin article-title 101
###xml 130 134 <span type="species:ncbi:10116">rats</span>
###xml 172 175 <span type="species:ncbi:10116">rat</span>
The effect of growth hormone and thyroxine on the amount of L-arginine:glycine amidinotransferase in kidneys of hypophysectomized rats. Purification and some properties of rat kidney transamidinase
###end article-title 101
###begin article-title 102
###xml 26 29 <span type="species:ncbi:10116">rat</span>
Cloning and sequencing of rat kidney L-arginine:glycine amidinotransferase. Studies on the mechanism of regulation by growth hormone and creatine
###end article-title 102
###begin article-title 103
###xml 90 95 <span type="species:ncbi:9031">chick</span>
Immunocytochemical demonstration of the binding of growth-related polypeptide hormones on chick embryonic tissues
###end article-title 103
###begin article-title 104
Regulation of vertebrate muscle differentiation by thyroid hormone: the role of the myoD gene family
###end article-title 104
###begin article-title 105
###xml 62 67 <span type="species:ncbi:9031">chick</span>
Extra-pituitary growth hormone in peripheral tissues of early chick embryos
###end article-title 105
###begin article-title 106
###xml 53 60 <span type="species:ncbi:9031">chicken</span>
Growth hormone in the male reproductive tract of the chicken: heterogeneity and changes during ontogeny and maturation
###end article-title 106
###begin article-title 107
Identification of a testis-expressed creatine transporter gene at 16p11.2 and confirmation of the X-linked locus to Xq28
###end article-title 107
###begin article-title 108
Duplication of a gene-rich cluster between 16p11.1 and Xq28: a novel pericentromeric-directed mechanism for paralogous genome evolution
###end article-title 108
###begin article-title 109
Development of the choroid plexus
###end article-title 109
###begin article-title 110
Development of the blood-brain barrier
###end article-title 110
###begin article-title 111
The choroid plexuses and the barriers between the blood and the cerebrospinal fluid
###end article-title 111
###begin article-title 112
###xml 26 29 <span type="species:ncbi:10116">rat</span>
Developmental decrease in rat small intestinal creatine uptake
###end article-title 112
###begin article-title 113
High-resolution 1H NMR spectroscopy of amniotic fluids from spina bifida fetuses and controls
###end article-title 113
###begin article-title 114
###xml 96 99 <span type="species:ncbi:9606">man</span>
Guanidinoacetate methyltransferase deficiency: the first inborn error of creatine metabolism in man
###end article-title 114
###begin article-title 115
Guanidinoacetate methyltransferase deficiency: new clinical features
###end article-title 115
###begin article-title 116
Therapeutic trial of arginine restriction in creatine deficiency syndrome
###end article-title 116
###begin article-title 117
Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect?
###end article-title 117
###begin article-title 118
Measurement of nitric oxide-related enzymes in brain by in situ hybridization
###end article-title 118
###begin article-title 119
###xml 81 84 <span type="species:ncbi:10116">rat</span>
Differential expression of the cationic amino acid transporter 2(B) in the adult rat brain
###end article-title 119

